Shlesha Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 04-07-2024
- Paid Up Capital ₹ 9.30 M
as on 04-07-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 109.32 Cr
as on 04-07-2024
- Satisfied Charges ₹ 5.00 Cr
as on 04-07-2024
About Shlesha Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 9.30 M.
The company currently has active open charges totaling ₹109.32 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Usha Jain, Prakash Shah, Shlesha Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC140147
- Company No.
140147
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2003
- Date of AGM
30 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shlesha Pharmachem?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shlesha Shah  | Director | 09-Aug-2021 | Current |
| Usha Jain | Director | 24-Apr-2003 | Current |
| Prakash Shah | Director | 24-Apr-2003 | Current |
| Budha Prajapat | Director | 09-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Shlesha Pharmachem.
Enhance accessibility to Shlesha Pharmachem's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shlesha Pharmachem?
Unlock access to Shlesha Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dtc Food Processors Private LimitedActive 23 years 6 monthsUsha Jain and Prakash Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 31 Dec 2007 | ₹24.50 Cr | Open |
Union Bank Of India Creation Date: 06 Feb 2007 | ₹12.25 Cr | Open |
Union Bank Of India Creation Date: 05 Feb 2007 | ₹12.25 Cr | Open |
How Many Employees Work at Shlesha Pharmachem?
Unlock and access historical data on people associated with Shlesha Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shlesha Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shlesha Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
